ACA vs AMGN · P/E 57, rev $2.88B vs P/E 24, rev $36.75B
Arcosa Inc (ACA) versus Amgen Inc (AMGN) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Not investment advice. Open the ACA and AMGN stock pages for the full models.
Not investment advice.